New Drug Candidate Blocks Resistance to Cancer Therapies
Michigan Medicine - University of MichiganA team of researchers at the University of Michigan Health Rogel Cancer Center has designed a molecule that impairs signaling mediated by two key drivers of cancer therapy resistance. The design and preclinical evaluation of the inhibitor, MTX-531 was published in Nature Cancer.